| Literature DB >> 33149943 |
Matteo Forlini1, Purva Date2, Domenico D'Eliseo3, Paolo Rossini3, Adriana Bratu3, Andrea Volinia3, Giovanni Neri4, Tommaso Verdina4, Maria Rosaria Carbotti4, Gian Maria Cavallini4, Luigi Sborgia5, Alessandra Galeone5, Aurelio Imburgia1, Alessandro Mularoni1, Alessandro Meduri6.
Abstract
PURPOSE: To evaluate whether limited vitrectomy is as effective as complete vitrectomy in eyes with epiretinal membrane (ERM) and to compare the surgical times and rates of complications.Entities:
Year: 2020 PMID: 33149943 PMCID: PMC7603613 DOI: 10.1155/2020/6871207
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Figure 1OCT scan of patient with limited vitrectomy with ERM removal. ((a)) Preoperative scan showing ERM with CMT of 472 μ with BCVA measuring 0.5 logMAR. ((b)) A one-month postoperative scan showing reduced CMT of 193 μ with BCVA improving to 0.8. ((c)) Yearly follow-up scan showing CMT 186 μ with normal foveal contour and vision improving to 0.9 logMAR.
Figure 2OCT scan of the patient with complete vitrectomy with ERM removal. ((a)) Preoperative scan showing ERM with loss of foveal contour, CMT measuring 563 μ, and BCVA measuring 0.5 logMAR. ((b)) The one-month postoperative scan showing a reduction in CMT to 266 μ with BCVA measuring 0.8. ((c)) After a year, CMT was 258 μ and BCVA improved to 0.9 logMAR.
Figure 3Limited vitrectomy: posterior vitreous detachment induction with “core vitrectomy.”
Figure 4Complete vitrectomy: peripheral vitreous removal with vitreous base shaving using dynamic preequatorial scleral indentation.
Figure 5Internal limiting membrane peeling after brilliant blue staining after ERM removal.
Baseline demographic and clinical characteristics of eyes in limited versus complete vitrectomy group.
| Variable | Limited vitrectomy ( | Complete vitrectomy ( |
|
|---|---|---|---|
| Age (years) | 71.03 ± 5.6 | 73.2 ± 7.8 | 0.06 |
| Gender (% men) | 35 (54%) | 38 (51%) | 0.77 |
| Eye (% right eye) | 38 (58%) | 43 (58%) | 0.96 |
| BCVA (logMAR) | 0.6 ± 0.1 | 0.5 ± 0.2 | 0.13 |
| Central macular thickness ( | 428 ± 93 | 454 ± 100 | 0.14 |
| Previous h/o retinal laser | 9 (14%) | 8 (11%) | 0.22 |
| Lens status: clear lens | 7 (11%) | 6 (8%) | 0.01 |
| Cataractous lens | 41 (63%) | 29 (39%) | |
| Pseudophakia | 17 (26%) | 39 (53%) | |
| Coexistent glaucoma (%) | 3 (5%) | 6 (8%) | 0.40 |
|
| |||
|
| |||
| Peripheral degenerations | 3 (5%) | 0 | 0.34 |
| Diabetic retinopathy | 2 (3%) | 1 (1.3%) | |
| High myopia | 0 | 2 (2.7%) | |
| Polypoidal choroidal vasculopathy (PCV) | 1 (1.3%) | 0 | |
Comparison of intraoperative characteristics in limited versus complete vitrectomy group.
| Variable | Limited vitrectomy ( | Complete vitrectomy ( |
|
|---|---|---|---|
|
| <0.001 | ||
| 23G | 19 (29%) | 29 (40%) | |
| 25G | 43 (66%) | 32 (43%) | |
| 27G | 3 (5%) | 13 (17%) | |
|
| |||
|
| <0.001 | ||
| ERM only | 17 (26%) | 2 (3%) | |
| ERM + ILM peeling | 48 (74%) | 72 (97%) | |
|
| |||
|
| <0.001 | ||
| Dual staining | 9 (14%) | 61 (82%) | |
| Brilliant blue dye | 39 (60%) | 3 (4%) | |
| Triamcinolone | 11 (17%) | 9 (12%) | |
| Others | 6 (9%) | 1 (1%) | |
| Phacoemulsification combined | 39 (60%) | 44 (59%) | 0.95 |
| Peripheral retinal breaks | 3 (5%) | 5 (7%) | 0.49 |
|
| |||
|
| <0.001 | ||
| Gas | 9 (14%) | 5 (7%) | |
| Air | 43 (66%) | 68 (92%) | |
| Saline | 13 (20%) | 1 (1%) | |
Comparison of duration of surgery of ERM + ILM peeling groups in limited versus complete vitrectomy groups.
| Duration of surgery (mins) | Limited vitrectomy | Complete vitrectomy | Total |
|
|---|---|---|---|---|
| 30–45 min | 2 (3.5%) | 15 (20%) | 17 (12%) | <0.0001 |
| 46–60 min | 58 (89%) | 37 (50%) | 95 (68%) | |
| 61–90 min | 3 (4%) | 17 (23%) | 20 (15%) | |
| 91–120 min | 2 (3.5%) | 4 (5.5%) | 6 (4.3%) | |
| >120 min | 0 (0%) | 1 (1.5%) | 1 (0.7%) | |
| Total | 65 (100%) | 74 (100%) | 139 (100%) |
Complications and outcomes of limited versus complete vitrectomy at the end of a 6-month follow-up.
| Variable | Limited vitrectomy ( | Complete vitrectomy ( |
|
|---|---|---|---|
| BCVA (logMAR) | 0.3 ± 0.2 | 0.22 ± 0.2 | 0.18 |
| Central macular thickness ( | 286 ± 87 | 358 ± 75 | 0.09 |
|
| |||
|
| |||
| Retinal detachment | 2 (3%) | 0 | 0.22 |
| Cystoid macular edema | 5 (8%) | 8 (11%) | 0.45 |
| Macular hole | 1 (1.5%) | 0 | |